ea0026oc4.3 | Diabetes/Thyroid | ECE2011
Tarasova L
, Klovins J
, Kalnina I
, Bumbure A
, Ritenberga R
, Geldnere K
, Nikitina-Zake L
, Pirags V
Objective: Metformin is one of the most widely used drugs in primary therapy for the treatment of type 2 diabetes (T2D). Despite its overall efficiency in T2D treatment metformin shows significant proportion of patients suffering from number of side effects. So far number of polymorphisms mainly in genes coding for various metformin transporter proteins have been described in association with metformin efficiency. However, no information exists on influence of genetic variatio...